IL115223A0 - Preparation containing antiresorptive compounds for use in the treatment of osteoporosis - Google Patents

Preparation containing antiresorptive compounds for use in the treatment of osteoporosis

Info

Publication number: IL115223A0
Authority: IL; Israel
Prior art keywords: osteoporosis; treatment; preparation containing; antiresorptive; compounds
Prior art date: 1994-09-09

Application number

IL11522395A

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-09

Filing date

1995-09-08

Publication date

1995-12-31

1995-09-08 Application filed by Procter & Gamble filed Critical Procter & Gamble

1995-12-31 Publication of IL115223A0 publication Critical patent/IL115223A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nutrition Science (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL11522395A 1994-09-09 1995-09-08 Preparation containing antiresorptive compounds for use in the treatment of osteoporosis IL115223A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US30398194A	1994-09-09	1994-09-09

Publications (1)

Publication Number	Publication Date
IL115223A0 true IL115223A0 (en)	1995-12-31

Family

ID=23174525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11522395A IL115223A0 (en)	1994-09-09	1995-09-08	Preparation containing antiresorptive compounds for use in the treatment of osteoporosis

Country Status (9)

Country	Link
EP (1)	EP0779813A4 (en)
JP (1)	JPH10505091A (en)
KR (1)	KR970705399A (en)
CN (1)	CN1157566A (en)
AU (1)	AU686019B2 (en)
CA (1)	CA2199251A1 (en)
IL (1)	IL115223A0 (en)
PE (1)	PE48597A1 (en)
WO (1)	WO1996007418A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS
EP1296689B3 (en)	2000-06-20	2013-02-13	Novartis AG	Method of administering bisphosphonates
PT1328277E (en) *	2000-10-27	2007-05-31	Schering Ag	Bisphosphonic compounds for strengthening of cortical bone
AU2006315132A1 (en)	2005-11-10	2007-05-24	Board Of Control Of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2509996A1 (en)	2009-12-07	2012-10-17	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5118667A (en) *	1991-05-03	1992-06-02	Celtrix Pharmaceuticals, Inc.	Bone growth factors and inhibitors of bone resorption for promoting bone formation
EP0618805A1 (en) *	1991-12-17	1994-10-12	PROCTER & GAMBLE PHARMACEUTICALS, INC.	Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

1995
- 1995-09-06 JP JP8509665A patent/JPH10505091A/en active Pending
- 1995-09-06 KR KR1019970701531A patent/KR970705399A/en not_active Application Discontinuation
- 1995-09-06 WO PCT/US1995/011336 patent/WO1996007418A1/en not_active Application Discontinuation
- 1995-09-06 AU AU36277/95A patent/AU686019B2/en not_active Ceased
- 1995-09-06 CA CA002199251A patent/CA2199251A1/en not_active Abandoned
- 1995-09-06 CN CN95195087A patent/CN1157566A/en active Pending
- 1995-09-06 EP EP95933745A patent/EP0779813A4/en not_active Withdrawn
- 1995-09-08 IL IL11522395A patent/IL115223A0/en unknown
1996
- 1996-03-12 PE PE1996000165A patent/PE48597A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPH10505091A (en)	1998-05-19
EP0779813A1 (en)	1997-06-25
EP0779813A4 (en)	1998-05-06
AU686019B2 (en)	1998-01-29
PE48597A1 (en)	1997-12-11
AU3627795A (en)	1996-03-27
CA2199251A1 (en)	1996-03-14
CN1157566A (en)	1997-08-20
WO1996007418A1 (en)	1996-03-14
KR970705399A (en)	1997-10-09

Similar Documents

Publication	Publication Date	Title
GB9407135D0 (en)	1994-06-01	Treatment of osteoporosis
PL318760A1 (en)	1997-07-07	Spiroazabicyclo compounds useful in medical treatment
ZA95556B (en)	1996-07-24	Combination treatment for osteoporosis
ZA988886B (en)	1999-04-12	Formulation for treatment of osteoporosis
AU4154796A (en)	1996-06-06	Compounds for the photodecontamination of pathogens in blood
HUP0102556A3 (en)	2002-12-28	Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
EP0699695A3 (en)	1997-10-01	Process for the preparation of copolyacetals
ZA954324B (en)	1996-01-25	Process for the preparation of 3-aryluracils
IL113248A0 (en)	1995-07-31	Use of alpha - 1c specific compounds
ZA951322B (en)	1995-10-23	Process for the preparation of polyalkyl-1-oxa-diazaspiro-decane compounds
GB9423868D0 (en)	1995-01-11	Compounds for use in medicine
IL121730A0 (en)	1998-02-22	Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
GB9424694D0 (en)	1995-02-01	Compounds for use in medicine
GB9509826D0 (en)	1995-07-05	Process for the preparation of imidazolutidine
IL115223A0 (en)	1995-12-31	Preparation containing antiresorptive compounds for use in the treatment of osteoporosis
IL115224A0 (en)	1995-12-31	Preparations for use in the treatment of osteoporosis
HUP9903852A3 (en)	2001-08-28	Process for the preparation of contrast agents
ZA891894B (en)	1989-11-29	Composition for the treatment of osteoporosis in humans
IL115225A0 (en)	1995-12-31	Preparations containing estrogen compounds for use in the treatment of osteoporosis
EP0755262A4 (en)	1997-05-07	Composition for the treatment of lung disease
EP0724842A3 (en)	1997-02-12	Preparation for the treatment of obesity
IL116493A0 (en)	1996-03-31	Process for the preparation of sameridine
ZA9510894B (en)	1996-02-15	Process for the preparation of chloromethylpyridines
EP0460690A3 (en)	1992-04-22	Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
EP0690056A3 (en)	1996-03-27	Process for the preparation of purins